-
Publication Venue For
-
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial..
397:2253-2263.
2021
-
Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial..
397:1545-1553.
2021
-
Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development..
397:1229-1236.
2021
-
Addressing the global burden of hearing loss..
397:945-947.
2021
-
A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial..
397:695-703.
2021
-
Global need: including rehabilitation in health system strengthening..
397:665-666.
2021
-
Mavacamten for hypertrophic obstructive cardiomyopathy..
397:369.
2021
-
First-attempt success rate of video laryngoscopy in small infants (VISI): a multicentre, randomised controlled trial..
396:1905-1913.
2020
-
COVID-19 in Brazil: the headlines should be about science..
396:1803.
2020
-
Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations..
396:1469-1471.
2020
-
Five insights from the Global Burden of Disease Study 2019..
396:1135-1159.
2020
-
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019..
396:1160-1203.
2020
-
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019..
396:1204-1222.
2020
-
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019..
396:1223-1249.
2020
-
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019..
396:1250-1284.
2020
-
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial..
396:959-967.
2020
-
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial..
396:759-769.
2020
-
Sex and gender: modifiers of health, disease, and medicine..
396:565-582.
2020
-
Recurrence of breast cancer after anaesthesia..
396:376.
2020
-
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study..
396:27-38.
2020
-
Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics..
395:1735-1738.
2020
-
Electron microscopy of SARS-CoV-2: a challenging task..
395:e99.
2020
-
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials..
395:1627-1639.
2020
-
Is the HScore useful in COVID-19?.
395:e83.
2020
-
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial..
395:1444-1451.
2020
-
Chagas disease: still a neglected emergency?.
395:1113-1114.
2020
-
Generating comparative evidence on new drugs and devices after approval..
395:998-1010.
2020
-
Antithrombotic treatment strategies after PCI..
395:866-867.
2020
-
From Hendra to Wuhan: what has been learned in responding to emerging zoonotic viruses..
395:e33-e34.
2020
-
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial..
392:2705-2717.
2019
-
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial..
394:2184-2196.
2019
-
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial..
394:2012-2024.
2019
-
Time to revisit indications for cholecystectomy..
394:1803-1804.
2019
-
Improved patient selection for implantable defibrillators..
394:1302-1304.
2019
-
Parallel community solutions for cardiovascular risk reduction..
394:1207-1208.
2019
-
High-quality evidence to inform clinical practice..
394:633-634.
2019
-
Building evidence and measuring clinical outcomes for genomic medicine..
394:604-610.
2019
-
Family health history: underused for actionable risk assessment..
394:596-603.
2019
-
Opportunities, resources, and techniques for implementing genomics in clinical care..
394:511-520.
2019
-
Department of Error..
393:e44.
2019
-
A Lancet Commission to address the global burden of hearing loss..
393:2106-2108.
2019
-
Sham trials: benefits and risks for cardiovascular research and patients..
393:2104-2106.
2019
-
Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..
393:1958-1972.
2019
-
Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology..
393:1045-1055.
2019
-
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial..
393:1021-1032.
2019
-
Heart failure drug treatment..
393:1034-1044.
2019
-
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials..
393:407-415.
2019
-
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017..
392:1684-1735.
2018
-
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017..
392:1736-1788.
2018
-
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..
392:1923-1994.
2018
-
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..
392:1859-1922.
2018
-
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017..
392:1789-1858.
2018
-
Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017..
392:2091-2138.
2018
-
Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017..
392:1995-2051.
2018
-
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial..
392:1519-1529.
2018
-
Age-related macular degeneration..
392:1147-1159.
2018
-
Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016..
392:1015-1035.
2018
-
Reimagining population health as convergence science..
392:367-368.
2018
-
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)..
392:232-243.
2018
-
Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study..
391:2631-2640.
2018
-
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial..
391:2346-2355.
2018
-
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016..
391:2236-2271.
2018
-
Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial..
391:1997-2007.
2018
-
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies..
391:1513-1523.
2018
-
Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition..
391:1224-1236.
2018
-
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial..
391:1174-1185.
2018
-
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial..
391:850-859.
2018
-
Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial..
391:741-747.
2018
-
Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST..
391:634-636.
2018
-
Reducing health disparities: Bar Ilan Medical School's care transition service..
391:533-534.
2018
-
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial..
391:205-218.
2018
-
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial..
391:219-229.
2018
-
Secondary prevention shifts into second gear..
391:181-182.
2018
-
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults..
390:2627-2642.
2017
-
Global hearing health care: new findings and perspectives..
390:2503-2515.
2017
-
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial..
390:2160-2170.
2017
-
Department of Error..
390:e38.
2017
-
Innovating through "interesting times" in global health..
390:e33-e34.
2017
-
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial..
390:1833-1842.
2017
-
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial..
390:1737-1746.
2017
-
Department of Error..
390:e23.
2017
-
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016..
390:1151-1210.
2017
-
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016..
390:1260-1344.
2017
-
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016..
390:1211-1259.
2017
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016..
390:1084-1150.
2017
-
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016..
390:1423-1459.
2017
-
The oldest-old in China - Authors' reply..
390:847.
2017
-
Cataracts..
390:600-612.
2017
-
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015..
390:231-266.
2017
-
Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial..
389:2214-2225.
2017
-
STREAM characterisation correction..
389:2102.
2017
-
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015..
389:1885-1906.
2017
-
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial..
389:1799-1808.
2017
-
Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: a cohort study..
389:1619-1629.
2017
-
ANTARCTIC: platelet function testing to adjust therapy..
389:1193.
2017
-
Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations..
389:951-963.
2017
-
Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study..
389:805-814.
2017
-
Early goal-directed mobilisation after surgery - Authors' reply..
389:695-696.
2017
-
Department of Error..
389:e1.
2017
-
Department of Error..
389:e1.
2017
-
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants..
389:37-55.
2017
-
Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial..
388:2895-2903.
2016
-
Assessment of economic vulnerability to infectious disease crises..
388:2443-2448.
2016
-
The effects of China's universal two-child policy..
388:1930-1938.
2016
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015..
388:1659-1724.
2016
-
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015..
388:1603-1658.
2016
-
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015..
388:1545-1602.
2016
-
Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015..
388:1775-1812.
2016
-
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015..
388:1459-1544.
2016
-
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015..
388:1725-1774.
2016
-
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015..
388:1813-1850.
2016
-
Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial..
388:1377-1388.
2016
-
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial..
388:1183-1192.
2016
-
Rhythm control in atrial fibrillation..
388:829-840.
2016
-
IxCELL-DCM: rejuvenation for cardiac regenerative therapy?.
387:2362-2363.
2016
-
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study..
387:2302-2311.
2016
-
Embolic central retinal artery occlusion after subcutaneous auricular steroid injection..
387:2235.
2016
-
Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials..
387:2026-2034.
2016
-
The Institute of Medicine: ensuring integrity and independence in scientific advice on health..
387:1686-1692.
2016
-
REGULATE-PCI trial--Author's reply..
387:1510-1511.
2016
-
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants..
387:1513-1530.
2016
-
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants..
387:1377-1396.
2016
-
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial..
387:1178-1186.
2016
-
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial..
387:661-670.
2016
-
A medical-toxicological view of tattooing..
387:395-402.
2016
-
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial..
387:349-356.
2016
-
Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial..
387:127-135.
2016
-
Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial..
387:136-145.
2016
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..
386:2287-2323.
2015
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition..
386:2145-2191.
2015
-
Radiation exposure in relation to the arterial access site used for diagnostic coronary angiography and percutaneous coronary intervention: a systematic review and meta-analysis..
386:2192-2203.
2015
-
Intracerebral haemorrhage, atrial fibrillation, and anticoagulation - Authors' reply..
386:1737.
2015
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..
386:743-800.
2015
-
Pharmacological and emerging therapies in the treatment of chronic angina..
386:691-701.
2015
-
Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs..
386:303-310.
2015
-
Tenofovir alafenamide for HIV infection: is less more?.
385:2559-2560.
2015
-
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial..
385:2485-2491.
2015
-
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial..
385:2477-2484.
2015
-
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial..
385:2465-2476.
2015
-
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)..
385:2363-2370.
2015
-
The theory and practice of imaging outcomes research..
385:2334-2335.
2015
-
Edoxaban and the need for outcomes-based NOAC dosing..
385:2232-2233.
2015
-
Aligning incentives to fulfil the promise of personalised medicine..
385:2118-2119.
2015
-
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials..
385:1397-1405.
2015
-
PHOTON-2: hope for patients with HIV and HCV co-infection?.
385:1052-1054.
2015
-
Time to treatment as a quality metric for acute STEMI care..
385:1056-1057.
2015
-
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial..
385:956-965.
2015
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..
385:117-171.
2015
-
A new era in medical therapy for retinal degenerative disease?.
384:1482-1484.
2014
-
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial..
384:1187-1195.
2014
-
Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply..
384:1097-1098.
2014
-
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..
384:1005-1070.
2014
-
Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013..
384:980-1004.
2014
-
China's distinctive engagement in global health..
384:793-804.
2014
-
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes..
383:2008-2017.
2014
-
Childhood cancer, endocrine disorders, and cohort studies..
383:1950-1952.
2014
-
Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis..
383:1059-1066.
2014
-
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial..
383:880-888.
2014
-
Stem-cell transplantation for chronic granulomatous disease..
383:390-392.
2014
-
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study..
382:1714-1722.
2013
-
Treatment of age-related macular degeneration..
382:1230-1232.
2013
-
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study..
382:614-623.
2013
-
Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial..
382:605-613.
2013
-
What is the optimum adjunctive reperfusion strategy for primary percutaneous coronary intervention?.
382:633-643.
2013
-
Exercise for late-life depression? It depends..
382:4-5.
2013
-
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial..
381:29-39.
2013
-
CT scans in childhood and risk of leukaemia and brain tumours..
380:1737-1738.
2012
-
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial..
380:1749-1758.
2012
-
Prediabetes and the risk of diabetes..
380:1225-1226.
2012
-
Pharmacogenetic guidance for antiplatelet treatment..
380:725.
2012
-
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials..
380:581-590.
2012
-
Prevalence of chronic kidney disease in China..
380:213-214.
2012
-
Age-related macular degeneration..
379:1728-1738.
2012
-
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial..
379:895-904.
2012
-
Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data..
379:322-334.
2012
-
Haemopoietic stem-cell transplantation for systemic sclerosis..
379:219.
2012
-
Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial..
378:997-1005.
2011
-
Antithrombin alternatives in STEMI..
378:643-645.
2011
-
Addressing the vaccine confidence gap..
378:526-535.
2011
-
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial..
377:1846-1854.
2011
-
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial..
377:1409-1420.
2011
-
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies..
377:1085-1095.
2011
-
Decompression illness..
377:153-164.
2011
-
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials..
376:1670-1681.
2010
-
Mixed messages on systemic therapies for diabetic retinopathy..
376:1461.
2010
-
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial..
376:1320-1328.
2010
-
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial..
376:1233-1243.
2010
-
Global operating theatre distribution and pulse oximetry supply: an estimation from reported data..
376:1055-1061.
2010
-
Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases..
376:922-927.
2010
-
Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial..
376:784-793.
2010
-
Tracking radiation exposure of patients..
376:754-755.
2010
-
Common genetic determinants of vitamin D insufficiency: a genome-wide association study..
376:180-188.
2010
-
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies..
375:2215-2222.
2010
-
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies..
375:1634-1639.
2010
-
Tracking China's health reform..
375:1056-1058.
2010
-
The role of academic health science systems in the transformation of medicine..
375:949-953.
2010
-
Eating disorders..
375:583-593.
2010
-
Liver disease in pregnancy..
375:594-605.
2010
-
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study..
375:283-293.
2010
-
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis..
375:132-140.
2010
-
Second primary cancers in survivors of childhood cancer..
374:1484-1485.
2009
-
Standardised metrics for global surgical surveillance..
374:1113-1117.
2009
-
Albuminuria in chronic heart failure: prevalence and prognostic importance..
374:543-550.
2009
-
Key issues for global cardiovascular medicine..
374:508-510.
2009
-
Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial..
373:1958-1965.
2009
-
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial..
373:1949-1957.
2009
-
Towards a common definition of global health..
373:1993-1995.
2009
-
The importance of VTE prevention after orthopaedic surgery..
373:1661-1662.
2009
-
Advancing care for acute heart failure--no time to relax..
373:1401-1402.
2009
-
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study..
373:1429-1439.
2009
-
Enjoying and enduring: groups reading aloud for wellbeing..
373:1339-1340.
2009
-
Public disclosure of clinical research..
373:1319-1320.
2009
-
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials..
373:1190-1197.
2009
-
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial..
373:1097-1104.
2009
-
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study..
373:919-928.
2009
-
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study..
373:739-745.
2009
-
Combination HIV prevention..
372:1805-1806.
2008
-
Reform of how health care is paid for in China: challenges and opportunities..
372:1846-1853.
2008
-
Community-based newborn care in Bangladesh..
372:1541.
2008
-
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya..
372:1555-1562.
2008
-
Tackling the challenges to health equity in China..
372:1493-1501.
2008
-
DIRECT new treatments for diabetic retinopathy..
372:1361-1363.
2008
-
Beta-blocker therapy in non-cardiac surgery..
372:1146-1147.
2008
-
The history and challenge of HIV prevention..
372:475-488.
2008
-
An estimation of the global volume of surgery: a modelling strategy based on available data..
372:139-144.
2008
-
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood..
371:2201-2212.
2008
-
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial..
371:1839-1847.
2008
-
Waterboarding is not torture: a physician's response..
371:1838.
2008
-
Immunisation against poliomyelitis: moving forward..
371:1385-1387.
2008
-
Fenofibrate and diabetic retinopathy..
371:721-722.
2008
-
PCI at non-PCI centres: immediate or rescue?.
371:534-536.
2008
-
Appropriate prescribing in elderly people: how well can it be measured and optimised?.
370:173-184.
2007
-
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study..
369:1947-1954.
2007
-
Pelvic organ prolapse..
369:1027-1038.
2007
-
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial..
369:907-919.
2007
-
Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients..
369:1099-1106.
2007
-
Sexual dysfunction in men and women with endocrine disorders..
369:597-611.
2007
-
Screening mammography at 40-49 years: regret or no regret?.
368:2035-2037.
2006
-
Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial..
368:1248-1253.
2006
-
Central nervous system injury associated with cardiac surgery..
368:694-703.
2006
-
Facilitated versus primary PCI for acute myocardial infarction..
367:1813.
2006
-
Trial summaries on results databases and journal publication..
367:1635-1636.
2006
-
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial..
367:29-35.
2006
-
Are the clinical effects of homoeopathy placebo effects?.
366:2081-2082.
2005
-
Are the clinical effects of homoeopathy placebo effects?.
366:2082-2083.
2005
-
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials..
366:2087-2106.
2005
-
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial..
366:2005-2011.
2005
-
The MANTRA II study..
366:1769.
2005
-
Blood vessels engineered from human cells..
366:891-892.
2005
-
Intermittent preventive malaria treatment in Tanzanian infants..
366:545.
2005
-
Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study..
366:211-217.
2005
-
Blood vessels engineered from human cells..
365:2122-2124.
2005
-
A man with chest pain and glomerulonephritis..
365:2062.
2005
-
CT colonography for detection of colon polyps and cancer..
365:1464-1465.
2005
-
Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison..
365:305-311.
2005
-
MRC CLASICC trial..
366:713.
2005
-
How much of China's success in tuberculosis control is really due to DOTS?.
364:391-392.
2004
-
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)..
363:852-859.
2004
-
International differences in evolution of early discharge after acute myocardial infarction..
363:511-517.
2004
-
Neuroprotective therapy for acute ischaemic stroke: down, but not out..
363:414-415.
2004
-
Selective decontamination of digestive tract in intensive care..
362:2117-2118.
2003
-
Does informed consent to research require comprehension?.
362:2016-2018.
2003
-
When clinical medicine collides with religion..
362 Suppl:s28-s29.
2003
-
Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis..
362:1605-1611.
2003
-
The CHARM programme..
362:1675-1676.
2003
-
Depression as risk factor for mortality after coronary artery bypass surgery..
362:1499-1500.
2003
-
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial..
362:777-781.
2003
-
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial..
362:772-776.
2003
-
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial..
362:767-771.
2003
-
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme..
362:759-766.
2003
-
Depression as a risk factor for mortality after coronary artery bypass surgery..
362:604-609.
2003
-
Concepts of blood transfusion in adults..
381:1845-1854.
2013
-
Antifibrinolytic therapy: new data and new concepts..
376:3-4.
2010
-
Diabetic retinopathy.
2010
-
Pancreatic cancer.
2004